Navigation Links
Linked to Liver Failure, Diet Supplement OxyElite Pro Recalled; Parker Waichman LLP Commends FDA for Invoking Rarely Used Enforcement Power in Letter to Supplements Maker
Date:11/13/2013

New York, New York (PRWEB) November 13, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, notes that Dallas-based USPlabs LLC is recalling certain OxyElite Pro dietary supplement products after receiving a letter from the U.S. Food and Drug Administration (FDA) stating that the products had been linked to liver illnesses and that there is a “reasonable probability” that the products were adulterated, according to a Nov. 10, 2013, press release issued by the FDA. The letter also notified USPlabs that if it did not initiate a voluntary recall, the FDA could by law order the company to immediately stop distributing the dietary supplements and immediately notify other parties to stop distributing the products, the press release added, noting that this marked only the second time that the FDA has exercised its recall authority under the FDA Food Safety Modernization Act (FSMA). The act was signed into law on Jan. 4, 2011, according to the FDA’s Food Guidance & Regulation webpage, last updated on Nov. 12.

“The FDA took this step to ensure that adulterated products do not reach the American public,” said Gary P. Falkowitz, a Managing Attorney at Parker Waichman LLP. “We support the FDA in this decision to show its willingness to use every power at its disposal to protect the American public from an allegedly dangerous supplement.”

According to the FDA press release, products that are part of this recall are OxyElite Pro Super Thermo capsules, OxyElite Pro Ultra-Intense Thermo capsules and OxyElite Pro Super Thermo Powder (available in the flavors fruit punch, blue raspberry, grape bubblegum and green apple). A full list of the products and their UPC codes can be found on the related page on the FDA website.

As further noted in its press release, the FDA notified USPlabs about findings indicating a link between the use of OxyElite Pro products and a number of liver illnesses reported in Hawaii. The FDA release also noted that cases of liver damage following the use of these OxyElite Pro products had also been found in a number of other states.

It added that, in a review of 46 medical records submitted to the FDA by the Hawaii Department of Health, 27 patients, or 58 percent, had taken a dietary supplement named OxyElite Pro before they became ill; 17 of the 27 patients (or 63 percent) reported that OxyElite Pro was the only dietary supplement that they were taking. One death has occurred among these patients, one patient has undergone a liver transplant, and others require transplants but are waiting for the organs to become available, the press release noted.

In a warning letter issued to USPlabs LLC on Oct. 11, 2013, the FDA informed the company that OxyElite Pro and another of its dietary supplements, called VERSA-1, had been deemed by the agency as “adulterated.” The letter pointed out that the products in question included aegeline, a new dietary ingredient that “lacks a history of use or other evidence of safety.” The letter also stated that failure to immediately cease distribution of all dietary supplements containing aegeline may result in enforcement action.

If you or someone you know has taken OxyElite Pro dietary supplement products, you may have valuable legal rights. To discuss your case with one of our lawyers, please view our website or call 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary P. Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/oxyelitepro_recall_fda/11/prweb11330967.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Sobriety, spirituality linked for teens in treatment
2. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Notes FDA Finding that Robotic Surgery Complications Linked to da Vinci Robot Doubled in Past Year
3. First genetic mutations linked to atopic dermatitis identified in African-American children
4. Endometriosis risk linked to 2 pesticides
5. Stem cells linked to cognitive gain after brain injury in preclinical study
6. Diabetes Increase Linked to Long Naps Released by Health News Wires
7. Earlier onset of puberty in girls linked to obesity
8. Increasing rate of knee replacements linked to obesity among young, researchers say
9. RNA build-up linked to dementia and motor neuron disease
10. Weight at time of diagnosis linked to prostate cancer mortality
11. Male birth defect is weakly linked to pesticide exposure, Stanford-led study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... development of Physiocrine-based therapeutics to address severe, rare diseases, today announced ... upcoming BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay ... December 14, 2016, at 4:20 p.m. ET. About ... ...
(Date:12/9/2016)... , Dec. 9, 2016 Department of Health ... regulations for medical marijuana dispensaries under Act 16 are ... , and are now available online . ... in the plan for operation; process for dispensing medical ... well as where the dispensary facilities can be located," ...
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
Breaking Medicine Technology: